Saving Organs. Saving Lives.
Introducing the Future of Organ Preservation
The VP.S ENCORE® is a premarket cardiac perfusion system designed to extend donor heart viability up to 8 hours.
It is currently undergoing preclinical evaluation under FDA Breakthrough Device Designation.
Engineered for Simplicity
Portable
Compact design, extended battery life, and single-person maneuverability support air travel over long distances without requiring specialized transportation.
Blood-free perfusate
Eliminates the need for donor blood, simplifying setup and reducing compatibility constraints.
Fail-safe Mode
Automatically shifts to cold static storage if perfusion is disrupted, protecting the life-saving organ.
Driven by Science. Guided by Urgency.
Every year, thousands of donor hearts go unused—not because they’re unviable, but because time, distance, and cost remain persistent barriers to preservation. At Vascular Perfusion Solutions, scientists and engineers are working with leading transplant surgeons to overcome these challenges through practical, purpose-built technology.
The VP.S ENCORE® is being developed to give recovery teams more time, more reach, and more options—without the complexity or high cost of existing systems. Our team is united by a single purpose: to make more organs transplantable and save more lives.
Regulatory Note: VP.S ENCORE® is an investigational device, currently in development and not yet approved for commercial use by the FDA. Any features or descriptions shown are for informational purposes only.